Equilis Prequenza 10 x 1 dosis
Staat het registratienummer van uw land er niet tussen? Dan betreft het een cascade product. Klik hier voor meer informatie.
Op Voorraad
Composition:
Per dosis of 1ml: A/equine-2/Newmarket/2/93 50 AU and A/equine-2/South-Africa/4/03 50 AU subunits from equine influenza viruses.
Indications:
Active immunisation of horses older than 6 months against equine influenza to reduce severity and duration of clinical signs and to reduce the amount and duration of viral shedding after infection. Onset of immunity is established two weeks after the basic vaccination. A priming response is maintained for up to 5 months after basic vaccination. The duration of immunity is up to 12 months after the first revaccination.
Dosage and administration:
Intramuscular injection of one dose (1 ml) per animal.
Vaccination schedule
Basic vaccination course
Foals should be vaccinated from the age of 6 months. Two vaccinations of one dose with a 4 week interval. The basic vaccination course results in immunity to equine influenza lasting at least 5 months.
Revaccination
The first revaccination (third dose) is given five months after the basic vaccination course. The revaccination results in immunity to equine influenza for at least 12 months. The second revaccination is given 12 months after the first revaccination.
Revaccination, at 12 month intervals of a suitable vaccine against equine influenza, such as Equilis® Prequenza or Equilis® Prequenza TE, both containing the strains A/equi 2/Newmarket-1/93 and A/equi 2/Newmarket-2/93, is recommended to maintain immunity levels against equine influenza.
